Xiaoxuan Kaduo Qu (消旋卡多曲)消旋卡多曲
This is a medicine registration record from NMPA data.本页为国家药监局药品注册记录。
Labeled sections from the recorded Chinese source are included below. English wording is a reference translation when one is on file, not an official English label.本记录未接入产品级适应症/安全性标注字段。
生产企业Manufacturer
- 四川升和药业股份有限公司Chinese legal name: 四川升和药业股份有限公司
主要成分Active Ingredients
- 消旋卡多曲Xiaoxuan Kaduo Qu
药物知识说明
消旋卡多曲是一种在国家药监局注册认定的药品。该药品含有消旋卡多曲-9159c2d0等成分。
该药品关联的活性成分包括：消旋卡多曲Xiaoxuan Kaduo Qu。这些成分信息来自国家药监局数据库。
该药品标注的生产企业为：四川升和药业股份有限公司Chinese legal name: 四川升和药业股份有限公司。
您可以探索含有相同成分的其他药品：消旋卡多曲-9159c2d0成分药品。
本页面内容来自国家药监局数据库，MedicineGraph在此基础上提供关系图谱和知识导航。
Medicine Knowledge
This medicine (original name: 消旋卡多曲) is a medicine registered with the national drug regulatory authority. It contains recorded ingredients as active ingredient(s).
Active ingredients associated with this product: 消旋卡多曲Xiaoxuan Kaduo Qu.
Manufacturers recorded for this product: 四川升和药业股份有限公司Chinese legal name: 四川升和药业股份有限公司.
Explore other medicines containing the same ingredient: 消旋卡多曲 productsProducts containing this recorded ingredient.
Source: MedicineGraph authoritative database. Relationships derived from registered product information.
这是什么What is this
- 通用名/品名Recorded product name: 消旋卡多曲Recorded Chinese name: 消旋卡多曲
- 规格Specification: ----
本段仅展示注册/说明书已记录的身份属性，不含适应症或用法建议。Identity attributes from registration/leaflet records only; no indications or usage advice.
主要成分Ingredients
生产企业Manufacturer
- 四川升和药业股份有限公司Chinese legal name: 四川升和药业股份有限公司
注册信息NMPA approval number
- 批准文号NMPA approval number: 国药准字H20058998
关联实体Relationships
信息来源Source and scope
国家药品监督管理局（中国）药品注册数据及已接入说明书字段。National Medical Products Administration (China) medicine-registration data and linked leaflet fields.
- 品名来源Name source: 10多万条药品说明书数据库 (HIGH)Package-insert database (more than 100,000 records) (HIGH)
- 生产企业来源Manufacturer source: 10多万条药品说明书数据库Package-insert database (more than 100,000 records)
范围：当前 MedicineGraph 注册记录及已记录的精确关系；非完整目录，亦不构成疗效等同主张，也不支持换用判断。不含适应症/安全性推断。Scope: current MedicineGraph registration records and exact recorded relationships; not a complete catalog and not a claim of therapeutic equivalence. No inferred indications/safety.
本段为已核准说明书原文摘录（非改写、非AI摘要），非正式英文标签，亦不构成用药建议。 Not an official English label and not medical advice. English wording, when shown, is a reference translation of the Chinese source label.
English translation for reference. Translated from the Chinese source label. Not an official English label and not medical advice.
NMPA approval number
国药准字H20058998
Manufacturer
Chinese legal name: 四川升和药业股份有限公司 (domestically manufactured)
Indications
English translation unavailable. The original Chinese source label remains available below.
Dosage and administration
English translation unavailable. The original Chinese source label remains available below.
Adverse reactions
English translation unavailable. The original Chinese source label remains available below.
Contraindications
English translation unavailable. The original Chinese source label remains available below.
Precautions
English translation unavailable. The original Chinese source label remains available below.
Storage
English translation unavailable. The original Chinese source label remains available below.
Specification
English translation unavailable. The original Chinese source label remains available below.
中文说明书原文Original Chinese source label
批准文号
国药准字H20058998
生产企业
四川升和药业股份有限公司(国产)
适应症
用于1月以上婴儿和儿童的急性腹泻,必要时与口服补液和静脉补液联合使用
用法用量
每日三次，每次按每公斤体重服用1.5 mg；单日总剂量应不超过6mg/Kg。
不良反应
偶见嗜睡、皮疹、便秘、恶心和腹痛等。
禁忌
肝、肾功能不全 ；不能摄入果糖，对葡萄糖或半乳糖吸收不良，缺少蔗糖酶、麦芽糖酶者禁用。
注意事项
1.连续服用本品5天后,腹泻症状仍持续者应进一步就诊或采用其他药物治疗方案; |2.本品可以和食物、水或母乳一起服用,请注意溶解混合均匀; |3.本品请勿一次服用双倍剂量; |4.与细胞色素酶P450-3A4抑制剂如红霉素、酮康唑(可能减少消旋卡多曲的代谢)同时治疗时慎用; |5.与细胞色素酶P450-3A4诱导剂如利福平(可能降低消旋卡多曲的抗腹泻作用)同时治疗时慎用。
贮藏
密封，置阴凉处。
规格
----
信息来源Source and scope
国家药品监督管理局（中国）药品注册数据。National Medical Products Administration (China) medicine-registration data.
范围：当前 MedicineGraph 注册记录及已记录的精确关系；非完整目录，亦不构成疗效等同主张，也不支持换用判断。Scope: current MedicineGraph registration records and exact recorded relationships; not a complete catalog and not a claim of therapeutic equivalence.